LEI 5493004K32AZP5PNOX30

INVEN2 AS

Awards tracked

94

Value

NOK 104.21M

€2.09M

Countries

NO

Download sample CSV

Contract awards & public grants

INVEN2 AS — Targeted combination influenza vaccine

Norges forskningsråd · NO · Grant · 2025-01-01

NOK 499,999

INVEN2 AS — Double-Edged Sword – A novel antibody targeting p95HER2 and HER2

Norges forskningsråd · NO · Grant · 2025-01-01

NOK 499,999

INVEN2 AS — “PharmaChip”: Robust, automated, and sustainable chemical analysis of organoids and organ-on-chip systems

Norges forskningsråd · NO · Grant · 2025-01-01

NOK 5M

INVEN2 AS — Deployable antenna for spacecrafts

Norges forskningsråd · NO · Grant · 2025-01-01

NOK 499,999

INVEN2 AS — The Tug-of-War Index: Advancing Precision Diagnostics and Treatment for Cardiac Patients

Norges forskningsråd · NO · Grant · 2025-01-01

NOK 499,999

INVEN2 AS — Smart Affinity Samplers with Cell Separation

Norges forskningsråd · NO · Grant · 2025-01-01

NOK 499,999

INVEN2 AS — Longitudinal Adjustable Resuscitation System (LARS)

Norges forskningsråd · NO · Grant · 2025-01-01

NOK 499,999

INVEN2 AS — CHRONOS: Faster and better diagnosis of brain disease

Norges forskningsråd · NO · Grant · 2025-01-01

NOK 5M

INVEN2 AS — AI-Based CT Perfusion Optimizing Stroke Care

Norges forskningsråd · NO · Grant · 2025-01-01

NOK 499,999

INVEN2 AS — Novel Drugs for Alzheimer’s Disease

Norges forskningsråd · NO · Grant · 2025-01-01

NOK 499,999

INVEN2 AS — Novel therapeutic strategies for pancreatic cancer

Norges forskningsråd · NO · Grant · 2025-01-01

NOK 499,999

INVEN2 AS — OMNI-EV: a Natural Killer cell derived vesicle-based platform technology for targeted cancer therapy

Norges forskningsråd · NO · Grant · 2025-01-01

NOK 5M

INVEN2 AS — Commercialization of a humanized next-generation antibody design for improved treatment of antibody-driven autoimmunity

Norges forskningsråd · NO · Grant · 2025-01-01

NOK 5M

INVEN2 AS — Multi-lumen glaucoma surgery stent

Norges forskningsråd · NO · Grant · 2025-01-01

NOK 5M

INVEN2 AS — A Biomarker-Based Tool for Early Diagnosis and Monitoring of Lupus Nephritis

Norges forskningsråd · NO · Grant · 2025-01-01

NOK 499,999

INVEN2 AS — Happy Hands - Hand osteoarthritis therapy App

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 499,857

INVEN2 AS — Novel vaccine platform for animal health

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 408,182

INVEN2 AS — A urine test for bladder cancer detection and monitoring

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 4.76M

INVEN2 AS — TandemAb – Validation of a novel antibody technology platform tailored for eradication of hard-to-kill cancer

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 5M

INVEN2 AS — Recovery of noble metals lost in high-temperature fertilizer production

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 500,000

INVEN2 AS — An expert radiological system for brain bleed measurement

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 499,896

INVEN2 AS — p95HER2 Antibody–drug conjugates (ADC)

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 499,999

INVEN2 AS — Confirming commercial feasibility of a superior endotoxin detection assay

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 345,999

INVEN2 AS — Switch receptor for use in adoptive cell therapy

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 499,999

INVEN2 AS — Total analytical solution for enabling robust mass spectrometric analysis of organoids and organ-on-chip samples

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 499,906

INVEN2 AS — Development of CAR-T therapy to treat ovarian cancer

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 484,565

INVEN2 AS — Glyco-specific antibodies and CAR-T for therapy and diagnostics of solid tumors

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 499,999

INVEN2 AS — Software for optimizing accessibility and memorability of text in marketing and communication

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 500,000

INVEN2 AS — NeoMedSys – Bringing research to the clinic

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 500,000

INVEN2 AS — Secretoneurin-related peptides to treat cardiac dysfunction and arrhythmia

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 488,176

INVEN2 AS — Light-assisted cryoprobe for eye surgery

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 499,999

INVEN2 AS — Bispecific antibodies to treat rheumatoid arthritis

Norges forskningsråd · NO · Grant · 2024-01-01

NOK 1.5M

INVEN2 AS — DogBiTE – a platform for validation of immunotherapeutic drugs

Norges forskningsråd · NO · Grant · 2023-01-01

NOK 499,999

INVEN2 AS — Safe Room - keeping patients safe through nights

Norges forskningsråd · NO · Grant · 2023-01-01

NOK 499,999

INVEN2 AS — CRISPR-Cas9 T cell editing pipeline for correcting monogenic mutations

Norges forskningsråd · NO · Grant · 2023-01-01

NOK 499,999

INVEN2 AS — Medical suction tip with enhanced functionality and efficiency

Norges forskningsråd · NO · Grant · 2023-01-01

NOK 499,999

INVEN2 AS — Biomarker for personalized therapy of breast cancer by de-escalating adjuvant chemotherapy

Norges forskningsråd · NO · Grant · 2023-01-01

NOK 489,479

INVEN2 AS — Absolut! - A tool for benchmarking ML-methods for Ab-Ag design

Norges forskningsråd · NO · Grant · 2023-01-01

NOK 499,999

INVEN2 AS — KVAL: Stabilizing Si as anode in Li-ion batteries

Norges forskningsråd · NO · Grant · 2023-01-01

NOK 483,999

INVEN2 AS — KVAL: A neural network-based image denoising software

Norges forskningsråd · NO · Grant · 2023-01-01

NOK 458,243

INVEN2 AS — Pharmacokinetics-on-a-chip

Norges forskningsråd · NO · Grant · 2023-01-01

NOK 499,999

INVEN2 AS — KVAL: Lumiblast™

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 499,999

INVEN2 AS — KVAL: Novel antibodies to treat chronic inflammation

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 308,579

INVEN2 AS — KVAL: Magic Bullets – Harnessing the power of T cell receptor loaded vesicles

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 495,619

INVEN2 AS — KVAL: Real-time newborn screening software

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 499,999

INVEN2 AS — KVAL: Tuned CAR-T cells – a novel platform technology

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 499,192

INVEN2 AS — KVAL: Crystalline polymorphs of Ga2O3 enable new transistors - PolymorFETs

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 499,999

INVEN2 AS — KVAL: Transcriptional addictions in cancer

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 499,999

INVEN2 AS — KVAL: Biomarkører som predikerer spredning av tarmkreft

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 443,523

INVEN2 AS — KVAL: Blood-based test for early detection of lung cancer

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 499,999

INVEN2 AS — KVAL: Mitophagy induction to treat Alzheimer’s disease – a hit-to-lead drug discovery project

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 499,999

INVEN2 AS — KVAL: Automated quantification of body composition from CT scans

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 335,099

INVEN2 AS — KVAL: Prostate cancer classifier

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 499,999

INVEN2 AS — Tankyrase inhibition as a therapeutic principle in idiopathic lung fibrosis

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 5M

INVEN2 AS — KVAL: CHRONOS – A tool for early detection of brain-tumor progression

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 499,999

INVEN2 AS — KVAL: A SUPERCONSTRUCT FOR OSTEOPOROTIC FEMUR FRACTURES

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 496,161

INVEN2 AS — KVAL: A novel drug for pancreatic cancer

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 498,018

INVEN2 AS — KVAL: All-Trans Retinoic Acid in Photodynamic Therapy

Norges forskningsråd · NO · Grant · 2021-01-01

NOK 274,893

INVEN2 AS — KVAL: CAR T cell therapy for metastatic cancer

Norges forskningsråd · NO · Grant · 2021-01-01

NOK 499,999

INVEN2 AS — KVAL: Oil-seed rape with increased seed retention

Norges forskningsråd · NO · Grant · 2021-01-01

NOK 499,999

INVEN2 AS — KVAL: Non-Invasive Diagnostic Tool for Heart Failure

Norges forskningsråd · NO · Grant · 2021-01-01

NOK 499,999

INVEN2 AS — KVAL: Tandem IgA-IgG antibodies

Norges forskningsråd · NO · Grant · 2021-01-01

NOK 498,975

INVEN2 AS — KVAL: Novel treatment for dry mouth

Norges forskningsråd · NO · Grant · 2021-01-01

NOK 457,480

INVEN2 AS — KVAL: Development of Clinical assay to predict treatment response in breast cancer

Norges forskningsråd · NO · Grant · 2021-01-01

NOK 499,999

INVEN2 AS — KVAL: Gene therapy for osteoarthritis and other inflammatory conditions

Norges forskningsråd · NO · Grant · 2021-01-01

NOK 499,999

INVEN2 AS — KVAL: Artificial liver organoids

Norges forskningsråd · NO · Grant · 2021-01-01

NOK 328,302

INVEN2 AS — KVAL: 5-ALA Extracorporeal Photopheresis for Chronic Inflammatory Disease

Norges forskningsråd · NO · Grant · 2021-01-01

NOK 499,999

INVEN2 AS — KVAL: Development of T cell receptor sequencing based method for diagnosing celiac disease

Norges forskningsråd · NO · Grant · 2021-01-01

NOK 499,991

INVEN2 AS — KVAL: Commercial development of CAR T-cells targeting CD37 or IgKappa/CD19

Norges forskningsråd · NO · Grant · 2021-01-01

NOK 429,999

INVEN2 AS — KVAL: Novel glaucoma surgery stent

Norges forskningsråd · NO · Grant · 2021-01-01

NOK 499,999

INVEN2 AS — DNA vaccine against pandemic influenza

Norges forskningsråd · NO · Grant · 2020-01-01

NOK 5M

INVEN2 AS — MP: Evaluating key elements to establish a globally oriented sales & development company with a pipeline of validated eHealth applications.

Norges forskningsråd · NO · Grant · 2020-01-01

NOK 499,999

INVEN2 AS — MP: Improved autoimmune therapy biologic

Norges forskningsråd · NO · Grant · 2020-01-01

NOK 487,974

INVEN2 AS — MP: WC hoop

Norges forskningsråd · NO · Grant · 2020-01-01

NOK 499,999

INVEN2 AS — KVAL: AlbuVax- Improved mucosal vaccine delivery

Norges forskningsråd · NO · Grant · 2020-01-01

NOK 499,999

INVEN2 AS — Juridisk Fokusgruppe II

Norges forskningsråd · NO · Grant · 2020-01-01

NOK 3.71M

INVEN2 AS — Norwegian Health Consortium

Norges forskningsråd · NO · Grant · 2020-01-01

NOK 8.5M

INVEN2 AS — MP: RoxEl – Realization of Oxide Electronics

Norges forskningsråd · NO · Grant · 2020-01-01

NOK 499,805

INVEN2 AS — MP: MyFood: a validated system that reduces malnutrition in health care.

Norges forskningsråd · NO · Grant · 2020-01-01

NOK 499,999

INVEN2 AS — MP: Analysis of Contagious Debt - AnaConDebt

Norges forskningsråd · NO · Grant · 2020-01-01

NOK 499,507

INVEN2 AS — Oppstartstilskudd: Pre-såkornfond

Innovasjon Norge · NO · Grant · 2019-08-19

€347,826

INVEN2 AS — HoloCare AS

Norges forskningsråd · NO · Grant · 2019-01-01

NOK 499,999

INVEN2 AS — Softbeam: Faster and better ultrasound imaging

Norges forskningsråd · NO · Grant · 2019-01-01

NOK 499,999

INVEN2 AS — Development of a more specific HPV test to improve and personalize follow-up of patients in the cervical cancer screening program

Norges forskningsråd · NO · Grant · 2019-01-01

NOK 417,466

INVEN2 AS — PDE2 inhibition: A novel and specific treatment for ventricular arrhythmias

Norges forskningsråd · NO · Grant · 2019-01-01

NOK 5M

INVEN2 AS — HLAII-targeting subunit vaccine for influenza and other infectious diseases

Norges forskningsråd · NO · Grant · 2019-01-01

NOK 499,999

INVEN2 AS — Manufacturing optimization for immunotherapeutic fusion protein targeting macrophages in solid tumors

Norges forskningsråd · NO · Grant · 2019-01-01

NOK 499,999

INVEN2 AS — New immune cell therapy for cancer through a unique TCR discovery platform

Norges forskningsråd · NO · Grant · 2019-01-01

NOK 499,999

INVEN2 AS — Commercialization of a cell therapy booster for industrial application

Norges forskningsråd · NO · Grant · 2019-01-01

NOK 118,134

INVEN2 AS — WNT/tankyrase inhibition in cancer therapy

Norges forskningsråd · NO · Grant · 2019-01-01

NOK 5M

INVEN2 AS — Oppstartstilskudd: Pre-såkornfond

Innovasjon Norge · NO · Grant · 2018-11-27

€434,783

INVEN2 AS — Oppstartstilskudd: Pre-såkornfond

Innovasjon Norge · NO · Grant · 2017-12-12

€434,783

INVEN2 AS — Oppstartstilskudd: Pre-såkornfond

Innovasjon Norge · NO · Grant · 2016-06-21

€521,739

INVEN2 AS — Oppstartstilskudd: Pre-såkornfond

Innovasjon Norge · NO · Grant · 2015-12-15

€347,826

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.